Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor

BACKGROUND: EGFR tyrosine kinase inhibitors (TKIs) have been developed for the treatment of EGFR mutated NSCLC. Parthenolide, a natural product of parthenolide, which belongs to the sesquiterpene lactone family and has a variety of biological and therapeutic activities, including anti-cancer effects...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Li, Xiaoling, Huang, Riming, Li, Mingyue, Zhu, Zheng, Chen, Zhiyan, Cui, Liao, Luo, Hui, Luo, Lianxiang
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686780/
https://ncbi.nlm.nih.gov/pubmed/33292235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01658-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados